3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Breast Neoplasms
23
Prostatic Neoplasms
8
Carcinoma, Intraductal, Noninfiltrating
3
Thyroid Nodule
2
Stomach Neoplasms
2
Pleural Effusion, Malignant
2
Mouth Neoplasms
2
Fibrosis
2
Carcinoma, Renal Cell
2
Carcinoma, Non-Small-Cell Lung
2
Wilms Tumor
1
Uterine Hemorrhage
1
Unspecified Adult Solid Tumor, Protocol Specific
1
Thromboembolism
1
Stomatitis
1
Somatostatinoma
1
Small Cell Lung Carcinoma
1
Sarcoma, Endometrial Stromal
1
Risk Malignant Index
1
Renal Insufficiency, Chronic
1
Rectal Neoplasms
1
Pheochromocytoma
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Oropharyngeal Neoplasms
1
Neurofibrosarcoma
1
Neurofibromatosis 1
1
Neoplasms
1
Melanoma
1
Lymphedema
1
Interventions
Rocuronium
2
ziprasidone
1
perflutren
1
peginesatide
1
hematide
1
Zolpidem
1
Warfarin
1
Vecuronium Bromide
1
Vancomycin
1
Tranexamic Acid
1
Tobramycin
1
Thalidomide
1
Spironolactone
1
Sevelamer
1
Piperacillin, Tazobactam Drug Combination
1
Pentobarbital
1
Oxycodone
1
Nifedipine
1
Nafcillin
1
Molindone
1
Methylprednisolone
1
Lurasidone Hydrochloride
1
Labetalol
1
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
1
High-Energy Shock Waves
1
Haloperidol
1
Fosfomycin
1
Dexamethasone
1
DM199
1
Clozapine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Renal Insufficiency, Chronic
×
High-Energy Shock Waves
×
Clear all
NCT03841149
2026-04-03
VolUS3D
Assistance Publique - Hôpitaux de Paris
Completed
53 enrolled